Company Promises Painless Glucose Monitoring
Diabetics around the globe have yearned for an alternative to the lancet and needle to monitor blood glucose levels. The wait may soon be over.
Norcross, Ga.-based SpectRx Inc. has developed a device that painlessly monitors a person's blood glucose level. A laser is used to create microscopic holes on the surface layer of the skin. A patch covers the area and monitors a clear interstitial fluid below the surface of the skin. The liquid contains concentrations of glucose similar to levels in the blood. The patch is worn for three days at a time with a beeper-size meter providing results every five minutes.
Unlike other developmental technologies, the SpectRx device would work without drawing blood, implanting a sensor or sending an electrical charge into the body. The company unveiled its prototype at the 17th annual Hambrecht and Quist Healthcare Conference in San Francisco in January.
LATEST NEWS
- Quantum Brilliance Raises $20M
Jan 16, 2025
- Scalable Error-Correction Signals Forthcoming Efficiency Gains for Quantum Compute
Jan 16, 2025
- Fraunhofer CAP Appoints Head, Scientific Director: People in the News: 1/15/25
Jan 15, 2025
- Bioluminescent Tags Track RNA Dynamics in Live Cells in Real Time
Jan 15, 2025
- Sensing and Inspection Specialist EVK Joins Headwall Group
Jan 14, 2025
- PHOTON IP Raises $4.9M Seed Round
Jan 14, 2025
- Graphene Prevents Damage to Flexible Thin Films for Wearable Electronics
Jan 14, 2025
- Thorlabs Acquires VCSEL Developer, Longtime Partner Praevium Research
Jan 13, 2025